Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect

PURPOSE: In 2013, Angelina Jolie disclosed in the New York Times (NYT) that she had undergone risk-reducing bilateral mastectomy (RRBM) after learning that she was a BRCA1 mutation carrier. We examined the rates of BRCA testing and RRBM from 1997 to 2016, and quantified trends before and after the J...

Descripción completa

Detalles Bibliográficos
Autores principales: Liede, Alexander, Cai, Mona, Crouter, Tamara Fidler, Niepel, Daniela, Callaghan, Fiona, Evans, D. Gareth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096880/
https://www.ncbi.nlm.nih.gov/pubmed/29808287
http://dx.doi.org/10.1007/s10549-018-4824-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096880/
https://www.ncbi.nlm.nih.gov/pubmed/29808287
http://dx.doi.org/10.1007/s10549-018-4824-9

Ejemplares similares